Previous Article | Next Article 
Journal of Virology, August 2000, p. 7250-7260, Vol. 74, No. 16
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Infectivity of Moloney Murine Leukemia Virus Defective in Late
Assembly Events Is Restored by Late Assembly Domains of Other
Retroviruses
Bing
Yuan,1
Stephen
Campbell,2
Eran
Bacharach,3
Alan
Rein,2 and
Stephen P.
Goff3,4,*
Integrated Program in Cellular, Molecular and
Biophysical Studies,1 Howard Hughes
Medical Institute,4 and Department of
Biochemistry and Molecular Biophysics,3 College
of Physicians and Surgeons, Columbia University, New York, New York
10032, and HIV Drug Resistance Program, National Cancer
Institute
Frederick Cancer Research and Development Center,
Frederick, Maryland 217022
Received 3 March 2000/Accepted 12 May 2000
 |
ABSTRACT |
The p12 region of the Moloney murine leukemia virus (M-MuLV) Gag
protein contains a PPPY motif important for efficient virion assembly and release. To probe the function of the PPPY motif, a series
of insertions of homologous and heterologous motifs from other
retroviruses were introduced at various positions in a mutant gag gene lacking the PPPY motif. The assembly defects of
the PPPY deletion mutant could be rescued by insertion of a wild-type
PPPY motif and flanking sequences at several ectopic positions in the Gag protein. The late assembly domain (L-domain) of Rous sarcoma virus
(RSV) or human immunodeficiency virus type 1 (HIV-1) could also fully
or partially restore M-MuLV assembly when introduced into matrix, p12,
or nucleocapsid domains of the mutant M-MuLV Gag protein lacking the
PPPY motif. Strikingly, mutant viruses carrying the RSV or the HIV-1
L-domain at the original location of the deleted PPPY motif were
replication competent in rodent cells. These data suggest that the PPPY
motif of M-MuLV acts in a partially position-independent manner and is
functionally interchangeable with L-domains of other retroviruses.
Electron microscopy studies revealed that deletion of the entire
p12 region resulted in the formation of tube-like rather than spherical
particles. Remarkably, the PPPY deletion mutant formed chain structures
composed of multiple viral particles linked on the cell surface. Many
of the mutants with heterologous L-domains released virions with
wild-type morphology.
 |
INTRODUCTION |
Virion particle assembly represents
a crucial late stage of the virus life cycle (31). Many
C-type retroviruses, such as human immunodeficiency virus type 1 (HIV-1), Rous sarcoma virus (RSV), and Moloney murine leukemia virus
(M-MuLV), assemble at the plasma membrane, where budding occurs
(31). During or soon after budding, the viral protease (PR)
is activated and virion proteins are cleaved to form mature particles
(2, 3, 33). The Gag protein plays an important role in the
entire assembly process (31, 35). The M-MuLV Gag precursor
protein comprises four separate domains, termed matrix (MA), p12,
capsid (CA), and nucleocapsid (NC) (20), and all these
regions are involved in different steps of viral assembly. The MA
domain is thought to be responsible for transporting the Gag precursor
and its associated proteins to the plasma membrane, CA directs the
formation of the virion core, and NC binds the viral RNA genome and
contains a major Gag-Gag interaction domain (31, 35). The
p12 region contains a PPPY motif, which is required for the efficient
assembly and release of M-MuLV virions (38).
Functionally, three assembly domains have been defined for the Gag
precursor protein, each apparently responsible for a separate function
in the assembly process. These domains are M (membrane association), L
(late assembly function), and I (interaction between Gag proteins).
L-domains, which are required for viral assembly and budding, have been
identified by detailed mutational analysis in many retroviruses
(19, 34, 36, 37). L-domains are found at quite different
regions of Gag in different viruses. In RSV and Mason-Pfizer monkey
virus (M-PMV), the L-domains contain a highly conserved PPPY motif as
the core sequence and are located between the MA and CA domains of the
Gag protein (34, 37). The L-domains of lentiviruses are
located at the C terminus of the Gag precursor protein and have
distinct core motifs, PTAPP in HIV-1 and YXXL in equine infectious
anemia virus (EIAV) (19, 22). It has been shown that the
L-domain sequences can be functionally interchanged among several
different viruses (HIV-1, RSV and EIAV) despite the lack of sequence
homology. Further, they can also function at unnatural sites in
chimeric Gag proteins (21, 22, 36). Therefore, the various
retroviral L-domains seem to act in a largely position-independent
manner and through a common mechanism (31). However, the
recovery of function by heterologous retrovirus L-domains was not
complete, and none of the chimeric viruses has been reported to be
replication competent (21, 22, 36). The molecular mechanisms
by which the L-domains may function to facilitate virion release are unknown.
We have previously reported that mutations affecting the PPPY motif of
the M-MuLV p12 protein cause defects in assembly or virion release
(38). We have now examined the block to virus production in
mutant M-MuLVs lacking the PPPY motif. The M-MuLV wild-type PPPY motif
and its flanking region, the p2b region of RSV, or the first 18 amino
acids of the HIV-1 p6 protein were inserted into several locations in
the coding region of M-MuLV Gag. Analysis by electron microscopy (EM)
showed that the PPPY motif functions at a very late stage in assembly,
perhaps at the release step itself. We also found that the PPPY motif
can be replaced by L-domains from other, unrelated retroviruses,
despite the lack of sequence identity between the L-domains, and that these domains can function at several sites in M-MuLV Gag. Most strikingly, two of these chimeras were fully infectious; thus, all of
the functions of PPPY in M-MuLV replication can be efficiently performed by L-domains from other retroviruses.
 |
MATERIALS AND METHODS |
Cells and viruses.
NIH 3T3 fibroblasts, 293T cells, and a
subclone of the Rat2 cell line (Rat2-2 cells) (11) were
maintained in Dulbecco's modified Eagle's medium containing
penicillin-streptomycin and 10% fetal calf serum. Wild-type (WT)
M-MuLV was harvested from 293T cells after transfection with the
plasmid pNCS.
Plasmids and mutants.
pNCS contains an infectious copy of
M-MuLV proviral DNA and carries a simian virus 40 replication origin to
allow high-level expression in 293T cells (8). pNCSB was
derived from pNCS by replacing the sequence CACTTTGAG (303 bp downstream from the 3' end of the gag gene) with
CACTTCGAA, creating a unique BstBI restriction site. The resulting virus encoded by pNCSB had a wild-type phenotype. Plasmids DPY-pNCS and DPY-pNCSB were similar to the wild-type parents
but contained a deletion that removed 5 amino acids (DPPPY) from p12
(Fig. 1) (38).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
Mutations in the M-MuLV Gag polyprotein. The M-MuLV Gag
protein is represented by rectangular boxes. The location of the PPPY
motif in the p12 region of the wild-type Gag protein is indicated. The
entire p12 region is deleted in the Del-p12 mutant. The DPY mutant
contains a 5-amino acid deletion (DPPPY) which removes the PPPY motif;
this mutant was used as the parent to generate the insertion mutants.
Three different fragments were used for the insertion mutants: PY, an
11-amino-acid fragment containing the wild-type PPPY motif and flanking
sequences from M-MuLV; p2b, the entire RSV p2b sequence (11 amino
acids) including the PPPPY motif; and P6, the N-terminal 18 amino acids
of the HIV-1 p6 protein including the PTAPP motif. The amino acid (aa)
sequences of PY, p2b, and P6 are as shown. The insertions are
represented by black boxes. The locations of insertions are as
indicated, with the names of the mutants on the left.
|
|
Mutations in MA and p12 were generated by PCR using a subclone of the
gag region between the unique BsrGI and
XhoI sites. The primers used to amplify the
BsrGI-XhoI fragment were BSRGI (forward)
(5'-CCTTTGTACACCCTAAGCC-3') and XHOIR (reverse)
(5'-GTCTGGGCGCTCGAGGGGAAAAGCG-3'). Insertions in NC were
also generated by PCR between the XhoI site and the
BstBI site of DPY-pNCSB. The primers used to amplify the XhoI-BstBI region were: XHOI (forward)
(5'-TTCCCCTCGAGCGCCCAGACTGG-3') and BSTBI (reverse)
(5'-TCCTGATCCTTCGAAGTGGATTTGGGCTTTTAG-3'). The Expand
High-Fidelity PCR system (Boeheringer Mannheim) was used to limit
possible random mutagenesis (4). The oligonucleotides used
to introduce mutations are shown in Table
1. The forward oligonucleotides were
labeled as XX-XX-F, while the reverse oligonucleotides were labeled as
XX-XX-R. To generate an insertion between the BsrGI and
XhoI sites, two intermediate PCR fragments, XX-XX-F/XHOIR and BSRGI/XX-XX-R, were first synthesized using plasmid DPY-pNCS as a
template. These two products, containing a large overlapping sequence,
were used as PCR templates, and the entire fragment between
BsrGI and XhoI was amplified by the flanking
oligonucleotide pair XHOIR and BSRGI. A similar strategy was applied to
generate insertions in the NC region, using DPY-pNCSB plasmid as a
template.
The amino acid sequences inserted into the mutant Gag protein are shown
in Fig. 1. The insertions were introduced into the following sites
(where the slash indicates the precise location of the insertion; amino
acid residues are numbered from the N terminus of the
Pr65gag protein): in MA, the site was between
amino acids Ser123 and Thr124 in the C-terminal
region (...ProProArgSer/ThrProProArg...); in p12, the
site was between amino acids Ala185 and Gly186
in the central region (...AlaThrProAla/GlyGluAlaPro...); and in
NC, the insertion site was between amino acids Gln530 and
Thr531 in the C-terminal region
(...ProArgProGln/ThrSerLeuLeu...). RSV P2 and HIV-1 P6
L-domains were also inserted into the original location of the PPPY
motif in the p12 region of the DPY mutant, which lacks 5 amino acids
(DPPPY). The insertion site was between amino acids Glu160
and Arg166 (...LeuLeuThrGlu/ArgAspProArg...). The
presence of all mutations was confirmed by DNA sequencing.
Analysis of virus assembly and infection.
293T cells were
transiently transfected by wild-type or mutant pNCS (or pNCSB) using
the calcium phosphate method. The culture medium was harvested 48 h posttransfection, and a standard reverse transcriptase (RT) assay was
performed to monitor virion production (32). The culture
medium was also used to infect fresh NIH 3T3 cells or Rat2-2 cells to
test the viability of mutant viruses. The infected cells were
maintained for up to 17 days, and the virus yields in the culture
supernatants were monitored by RT assay daily. Infections of NIH 3T3
cells and Rat2-2 cells were carried out in the presence of Polybrene (8 µg/ml).
To study viral DNA synthesis in the infected cells, fresh NIH 3T3 cells
were acutely infected with equal amounts of virus normalized by RT
activity in the culture medium from transfected 293T cells.
Preintegrative viral DNAs were extracted from cells 24 h
postinfection (16) and analyzed by Southern blotting.
Viral particle purification and analysis.
At 48 h after
transfection of 293T cells with wild-type or mutant proviral DNAs, 6 ml
of culture supernatant was collected from each 100-mm-diameter plate of
transfected cells. Cell debris was removed by filtering the medium
through a 0.45-µm-pore-size filter, and HEPES buffer was added to a
final concentration of 20 mM. Virions were purified by
ultracentrifugation through sucrose cushions as described previously
(38).
The pelleted virus particles were lysed and subjected to Western blot
analysis (38). The antisera used in the Western blot assays
included goat anti-CA serum (NCI serum 79S-804), goat anti-p12 serum
(NCI serum 78S-276), and goat anti-MA serum (NCI serum 78S-282). The
monoclonal antiserum against the transmembrane (TM) envelope protein
was collected from a rat hybridoma line (42-114) (14).
Quantitative study of virus infectivity.
293T cells at about
70% confluence in 100-mm diameter plates were transiently
cotransfected with 10 µg of pSR-LLuc (a plasmid DNA encoding a
retroviral vector transducing luciferase) (1) and 10 µg of
a plasmid DNA encoding the indicated virus, using the calcium phosphate
method. The cells were incubated in 10 ml of Dulbecco's modified
Eagle's medium-fetal calf serum for 2 days, after which the RT
activity in the culture supernatants was assayed. To test for virus
helper function, the culture medium was filtered through
0.45-µm-pore-size filters after the addition of 20 mM HEPES (pH 7.4)
and Polybrene (8 µg/ml) and 4 ml of the filtrate were used to infect
1.2 × 106 Rat2-2 cells in 100-mm plates for 2 h.
Lysates of infected cells were prepared 2 days after infection and
analyzed for specific luciferase activity using a luminometer (Lumat LB
9501; Berthold) and a luciferase assay system (Promega) as specified by
the manufacturer. The total protein concentration in cell lysates was
determined using a protein assay kit (Bio-Rad). The specific activity
of luciferase was calculated as relative light units per milligram of
total protein. The luciferase activity of the infected cells was
corrected for variation in the RT levels of the supernatants of the
transfected cells. Mock-transfected and infected cells (no plasmid DNA
or virus added) were used to subtract background levels from the RT and
luciferase activities. A 1:10 dilution of the supernatants gave a
10-fold reduction in the luciferase activity, suggesting that
infections were done at a multiplicity in the linear range (data not shown).
EM analysis.
293T cells were transfected with wild-type or
mutant pNCS plasmids, and 48 h after transfection the cells were
fixed with 2% glutaraldehyde in 0.1 M sodium cacodylate. The cells
were further fixed with 2% OsO4 for 2 h and then
dehydrated with a graded series of ethanol dilutions ranging from 30 to
100% before being embedded in Epon resin. Thin sections were
counterstained with 1% lead citrate and 2% uranyl acetate before
being examined by transmission electron microscopy.
 |
RESULTS |
Construction of insertion mutants.
The M-MuLV p12 protein
contains a PPPY motif that is important for virus assembly or release.
Deletion or alanine substitution of this motif caused severe defects in
virion production, Gag protein processing, and TM protein cleavage
(38). To determine whether this domain acts in a
position-independent manner, a series of insertion mutations were
introduced into a mutant M-MuLV gag gene encoding a protein
lacking the PPPY motif, specifically containing a deletion of the 5 amino acids DPPPY. A sequence encoding 11 amino acids, the PPPY motif,
and flanking sequences from the wild-type M-MuLV was inserted into
ectopic sites in the gag gene, resulting in a peptide
inserted in the middle region of p12, the C terminus of MA, or
the C terminus of NC (PY-P12, PY-MA, and PY-NC [Fig. 1]). The
insertion sites were chosen insofar as possible to avoid effects
on known protein functions.
To determine whether the M-MuLV L-domain is functionally
interchangeable with the L-domains of other retroviruses, DNAs encoding the entire p2b protein of RSV (including the PPPPY motif) and the first
18 amino acids of the HIV-1 p6 protein (including the PTAPP motif) were
inserted into the original location of the PPPY motif (P2-PY and
P6-PY). The p2b and p6 L-domains were also inserted into the same
locations of p12, MA, or NC as the wild-type M-MuLV PPPY motif in the
mutants described above (P2-P12, P2-MA, P2-NC, P6-P12, P6-MA and P6-NC
[Fig. 1]).
Virion production by chimeric mutants.
To test whether the
newly inserted sequences could rescue the defects of the parental
PPPY deletion mutant, 293T cells were transiently transfected with the
mutant proviruses by the calcium phosphate precipitation method.
Culture supernatants were collected 48 h after transfection, and
the released particles were analyzed by the RT assay. All the insertion
mutants showed increased RT activity compared to the PPPY deletion
mutant DPY (Fig. 2A). Quantitation of the
RT activity revealed that the PPPY deletion mutant produced less than
20% of the levels of virion-associated RT of the wild-type virus. The
viruses carrying the inserted copy of the wild-type PPPY at the middle
region of p12 (PY-P12) or the C-terminal region of MA (PY-MA) exhibited
RT activity equal to that of the wild-type virus, while the virus
carrying the same sequence in the C-terminal region of NC (PY-NC)
produced RT activity approximately 50% of that of the wild type.
Viruses carrying the RSV p2b at p12, MA, or NC yielded levels of RT
comparable to those of viruses carrying the wild-type PPPY motif in the
corresponding Gag regions (P2-P12, P2-MA, and P2-NC). Furthermore,
insertion of p2b into the location of the original PPPY motif also
restored 100% of the RT activity of the wild type (P2-PY). In
contrast, viruses carrying the HIV-1 p6 L-domain at p12 or MA showed
only 40 to 50% of the wild-type RT activity (P6-P12 and P6-MA).
However, the viruses showed nearly normal RT activity when the p6
L-domain was inserted into the original PPPY location (80% of
wild-type RT activity [P6-PY]) or the NC region (100% of wild-type
RT activity [P6-NC]) (Fig. 2B). These results suggest that the M-MuLV
L-domain can act in other locations and that its function can be
efficiently provided by other retroviral L-domains. However, different
L-domains displayed distinct preferences for their original location in
the Gag protein in providing optimal function.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
Viral assembly and particle release analyzed by the RT
assay. (A) RT activity in the culture supernatant. The proviruses of
the insertion mutants were transiently transfected into 293T cells by
calcium phosphate precipitation, and supernatants were analyzed by the
RT assay 48 h after transfection. (B) PhosphorImager quantitation
of the relative RT activity in produced virions. The mean of three
independent experiments is shown. Error bars indicate standard
deviation of the three results. The amount of RT activity in the
wild-type (WT) virus is set as 100.
|
|
Gag gene products in virions and transfected 293T cells.
The
parental PPPY mutant showed major defects in viral protein processing
normally associated with virion maturation. To test whether the new
insertions could rescue the defects of viral Gag protein processing,
culture supernatants from transfected 293T cells were
collected and the virions were purified by ultracentrifugation through
sucrose cushions. The virion lysates were subjected to RT assays to
monitor the recovery of virions through the purification process (data
not shown), and the virion-associated proteins were then analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and Western blotting. Anti-CA, anti-MA, or anti-p12 polyclonal antisera
were used to detect the corresponding gag gene products. As
previously reported (38), the PPPY deletion mutant (DPY) showed defects
in Gag protein processing: an increased level of the unprocessed
Pr65gag precursor protein was observed, and
nearly no mature p12 or MA proteins could be detected in the virions
(Fig. 3A to C). Gag processing was almost
fully restored in several mutants carrying the homologous sequence
(PY-P12 and PY-MA), several carrying the RSV sequence (P2-PY, P2-P12,
and P2-MA), and one carrying the HIV-1 sequence (P6-NC). However, other
mutants, PY-NC, P2-NC, P6-PY, P6-P12 and P6-MA, still showed partial
defects in Gag protein processing (Fig. 3A to C), and smaller amounts
of MA proteins were detected in these virions (Fig. 3B). Insertions
into MA and p12 caused the corresponding MA and p12 proteins to migrate
differently in the SDS-PAGE (Fig. 3B and C). Only very weak p12 bands
could be detected in those mutants with the PPPY motif deletion
(Fig. 3C), suggesting that the PPPY motif and flanking regions
may be the major recognition site for the anti-p12 antibody used in
these blots. Insertion mutagenesis caused the p12 proteins of several mutants (PY-P12, P2-PY, P2-P12, P6-PY, and P6-P12) to migrate at
similar positions to the MA protein in the SDS-PAGE gel and were thus
hard to detect (Fig. 3C). However, the data clearly indicate that Gag
protein processing could often be restored by inserting a new copy of
this domain into other locations of the Gag protein or by inserting the
L-domains of other retroviruses.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 3.
Western blot analysis of gag gene products in
virions and in lysates of transfected cells. The virus particles were
collected by ultracentrifugation from the culture supernatants of the
transfected 293T cells. The virions were lysed, and proteins were
subjected to Western blot analysis. Blots were probed with polyclonal
antisera against CA (A), MA (B), and p12 (C). The anti-p12 antiserum
also showed contaminating reactivity to MA. (D) Lysates of transfected
293T cells were also analyzed by Western blotting using anti-CA
polyclonal serum. The positions of Pr65gag, CA,
MA, and p12 are indicated. WT, wild type.
|
|
To ensure that the viral proteins were expressed normally in the
transfected 293T cells, cell lysates were also prepared 48 h after
transfection and the intracellular viral proteins were analyzed by
Western blotting. The levels of CA and Pr65gag
proteins found in the cells expressing all of the mutants were similar
to those seen in cells expressing the wild type. For mutants DPY,
P6-P12, and P6-MA, slightly more unprocessed
Pr65gag precursor protein was detected in the
lysates than in the controls, suggesting that in these mutants the
defect in virion budding was more severe and that a larger amount of
Gag protein was retained in the transfected cells (Fig. 3D).
TM protein processing in the new insertion mutants.
Mutants
lacking the PPPY motif mutants exhibited a complete block in the
cleavage of the C-terminal tail of the TM envelope protein from p15E to
p12E (38) (Fig. 4). It has
been shown that mutations blocking the proteolytic processing of the TM
cytoplasmic tail result in noninfectious virus (24, 25). To
test for restoration of this cleavage, virions were purified from the
culture supernatants of transfected 293T cells by ultracentrifugation,
and cleavage of the TM protein was analyzed by SDS-PAGE and Western
blotting. Several of the insertion mutants, including PY-P12, PY-MA,
P2-PY, and P2-MA, processed the TM protein almost as efficiently as the wild-type virus did (Fig. 4). For other mutants, the extent of recovery
of TM cleavage was less than complete. P6-P12, P6-MA, PY-NC, and P2-NC
showed only poor cleavage. These data correlated well with the Gag
protein-processing results (Fig. 3). Therefore, several different
L-domains inserted in different locations of the M-MuLV Gag protein can
complement the defects of the TM envelope protein processing of the
PPPY mutant.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of TM envelope protein in mutant virions.
Virions were harvested, and proteins were analyzed by Western blotting.
A TM-specific monoclonal antiserum was used to detect p15E and p12E
forms of the TM protein. The positions of p15E and p12E are indicated.
WT, wild type.
|
|
Viral DNA synthesis in infected NIH 3T3 cells.
The DPY mutant
carrying a deletion of the PPPY motif is replication defective. The
deletion not only severely reduced virion assembly but also blocked the
ability of the virions to carry out synthesis of most of the linear and
all the circular viral DNAs in infected NIH 3T3 cells. To determine
whether the insertions could rescue the defects of the DPY mutant in
the early events of the virus life cycle, virus supernatants from
transfected 293T cells were collected and used to acutely infect fresh
NIH 3T3 cells. The virus levels in these infections were normalized by RT activity. The low-molecular-weight DNAs were extracted 24 h after infection, and the viral DNAs were analyzed by Southern blotting
with a virus-specific DNA probe. The same Southern blot membrane was
then stripped and hybridized with a mitochondrial DNA probe to monitor
recovery of the DNA. For the DPY mutant, the levels of linear viral DNA
were less than 10% of those seen for the wild-type virus and no
circular DNAs were detected, consistent with the results reported
previously (38). Mutants P2-PY and P6-PY, in which the RSV
p2b and HIV-1 p6 L-domains, respectively, were inserted into the
original location of the PPPY motif, could both synthesize linear and
circular viral DNAs, although the total amount of viral DNA was
somewhat less than that of the wild-type control (Fig.
5). Most of the other mutants could
direct the synthesis of linear DNA to various extents, but none of them
could make detectable levels of circular viral DNA (Fig. 5).

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 5.
Southern blot detection of linear and circular viral
DNAs synthesized in infected NIH 3T3 cells. Supernatants from
transfected 293T cells were used to acutely infect NIH 3T3 cells. The
virus titers in the supernatants were normalized for RT activity.
Low-molecular-weight DNAs were extracted by the Hirt method, and the
viral DNAs were detected by hybridization with a radiolabeled
virus-specific DNA probe. The same membrane was stripped and
rehybridized with a mitochondrial DNA probe to monitor
the recovery of DNA loaded in each lane. The positions and sizes of
linear and two circular viral DNAs are marked. WT, wild type.
|
|
Mutants PY-NC and P2-NC, containing insertions of the wild-type PPPY
motif or p2b into NC, resulted in even less viral DNA production than
the DPY mutant (Fig. 5). The NC protein plays an important role in the
early events of the life cycle, particularly reverse transcription
(5, 12, 18), and these insertions into NC may have affected
its function during viral DNA synthesis.
Viability of insertion mutants.
Since some of the insertion
mutants showed substantially normal levels of virion production and
viral DNA synthesis, it was possible that a subset of these viruses
could be fully replication competent. To test for viral replication,
culture supernatants of transfected 293T cells were used to infect
fresh NIH 3T3 cells and virion yields in the cultures were monitored by
RT assays daily. As expected, the wild-type virus could efficiently
infect and spread in the culture, and strong RT activity could be
detected within 2 days after infection. The DPY mutant remained
replication defective (Fig. 6). Mutants
P2-PY and P6-PY produced progeny virus as quickly as the wild-type
virus did (Fig. 6). These data suggest that the heterologous retroviral
L-domains can fully replace the M-MuLV L-domain when placed in the
original location of the PPPY motif, even though the HIV-1 p6 L-domain
does not bear primary sequence similarity to the L-domain of M-MuLV. As
described above, Gag and TM protein processing for mutant P2-PY was
similar to that for the wild type. However, mutant P6-PY exhibited
partial defects in virion production and in Gag and TM protein
processing (Fig. 2 to 4). Despite these defects, this mutant virus was
still infectious. Therefore, the modest defects in assembly and protein processing exhibited by this mutant were not limiting in the
replication of the mutant virus.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 6.
Virus infectivity. Equal volumes of culture medium from
transfected 293T cells were collected 48 h after transfection and
used to infect naive NIH 3T3 cells. Culture supernatants were harvested
every day up to 17 days, and the virus yield was monitored by the RT
assay. The RT assay results from day 2 to day 9 are shown. The days
when cultures were split are marked. WT, wild type.
|
|
None of the remaining mutants were infectious, even though the particle
release and protein processing of mutants PY-P12, PY-MA, P2-P12,
P2-MA, and P6-NC were comparable to those of the wild-type virus
(Fig. 3 to 6). For mutants PY-P12 and PY-MA, low levels of RT activity
were detected after 13 days. Whether these signals were due to
extremely limited replication of the mutant or to the appearance of
revertants is not known. Similar results were obtained when Rat2-2
cells were used instead of NIH 3T3 cells (data not shown).
Analysis of virion proteins and viral DNA sequences of the viable
mutants.
To ensure that the apparent viability of mutants P2-PY
and P6-PY could not be attributed to contamination from wild-type
virus, recombination with endogenous DNAs, or reversion, the culture supernatants from infected NIH 3T3 cells were collected on day 6 and
the virions were pelleted by ultracentrifugation. The viral particles
were lysed and subjected to Western blot analysis. Protein processing
of mutant P2-PY was similar to that of wild-type virus, but mutant
P6-PY remained partially defective for both Gag and TM protein cleavage
(Fig. 7). These phenotypes were identical to those of mutant viruses obtained from transient transfection (Fig.
3, 4 and 7). As expected, the p12 proteins of both mutants migrated
slower than that of wild-type virus on an SDS-PAGE gel because of the
insertions (Fig. 7C).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 7.
Western blot analysis of virion proteins in the
replication-competent chimeric mutants. The culture supernatants of
infected NIH 3T3 cells in Fig. 6 were collected on day 6. The viral
particles were pelleted by ultracentrifugation, lysed, and analyzed by
Western blotting. The membranes were probed with anti-CA (A), anti-MA
(B), anti-p12 (C) polyclonal antiserum. (D) In addition, a specific
monoclonal antibody was used to detect TM envelope protein. The
anti-p12 polyclonal antiserum also showed contaminating reactivity with
MA. The positions of Pr65gag, CA, MA, and p12
are indicated. WT, wild type.
|
|
After the infected NIH 3T3 cells were cultured for 17 days, the
supernatants of these two mutant viruses were harvested and used to
infect fresh NIH 3T3 cells. The viral DNAs were isolated 24 h
after infection by using the Hirt method. The viral DNA fragments between the BsrGI and XhoI sites were amplified
by PCR and cloned into a plasmid vector. DNA sequencing demonstrated
that the original insertions of the p2b and p6 L-domains into the PPPY
location remained intact in the P2-PY and P6-PY mutants. No other
mutations were found in the insertion region between BsrGI
and XhoI. These data strongly suggest that the infectious
chimeric viruses replicating in the NIH 3T3 cells were the original
P2-PY and P6-PY mutants, although we cannot completely rule out the
possibility that suppressor mutations could have occurred outside the
insertion region.
Quantification of the infectivity of DPY, P2-PY, and P6-PY in a
single round of infection.
Although the above experiments suggest
that two chimeric viruses can replicate, they do not provide an
estimate of the efficiency of infection. To quantitatively measure the
efficiency of a single round of replication, the ability of the DPY,
P2-PY, and P6-PY viruses to provide helper function in trans
for the transduction of a retroviral vector was tested. 293T cells were
transfected with the helper DNAs plus a vector carrying the luciferase
reporter gene, virus was collected, and the efficiency of transfer was assessed by measuring the luciferase levels present in extracts of
Rat2-2 cells after infection. The DPY virus failed to mediate transduction of cells by the retroviral vector (the luciferase specific
activity was 0.5% of that present after infection mediated by
wild-type helper). In contrast, the P2-PY and P6-PY viruses transduced
cells with approximately 10 and 20% of the efficiency of the wild-type
virus, respectively. These results demonstrate that the RSV p2 and the
HIV-1 p6 sequences partially rescued the infectivity of the DPY virus.
EM analysis of particles released by mutants.
Deletion of the
entire p12 protein or the PPPY motif of M-MuLV leads to significant
reductions in virion production and viral protein processing
(38). However, the exact stage in the process of assembly or
budding that is affected by the mutation is not clear. To determine the
effects of the mutations on virion morphology, producer cells were
examined by EM. 293T cells were transfected with the wild-type or
mutant (Del-p12 and DPY) proviruses and fixed 48 h after
transfection. The samples were embedded, sectioned, and stained, and
sections were examined under the electron microscope. The wild-type
mature viruses appeared as round particles with a condensed, concentric
core. In the immature budding viruses, the particles were characterized
by a spherical structure with an electron-lucent center, giving a
doughnut-shaped appearance (Fig. 8A).
Surprisingly, cells expressing the Del-p12 mutant produced abnormal
particles with elongated tube-like structures (Fig. 8B). The tubes were
generally 300 to 500 nm in length and two-thirds to three-quarters of
the diameter of normal immature virus. Most of the rods were still
attached to the cell membrane and contained a head or cap at one end.
The heads of the tubes showed a structure similar to that of the
immature budding viruses. There were also low levels of spherical
immature virions but no mature viral particles (Fig. 8B). It is not
clear whether the few "immature particles" are simply sections
through the "heads" at the ends of the tubes.

View larger version (120K):
[in this window]
[in a new window]
|
FIG. 8.
EM images of 293T cells expressing wild-type and mutant
viral genomes. (A) Wild-type virus particle release. The mature viruses
are marked by black arrows, and the immature viruses are marked by
white arrows. (B) Particle release from the Del-p12 mutant. The
tube-like structures are indicated by white arrows. A black arrow
points to a cross-section of a tube. (C) Particle release from the DPY
mutant. The multiple virus chain structures are marked by black arrows,
and tubes are indicated by white arrows. Bars, 200 nm.
|
|
The DPY mutant assembled chain-like structures containing several
spherical immature viruses connected by bridges (Fig. 8C). In the
multiple-chain structures, the immature virions appeared to emanate
from the cell membrane one after another to form a linear chain or
branches. The virions were connected with each other by a narrow neck;
typically two to five virions were chained together (Fig. 8C). There
were also occasional tube-like structures and no mature virions. These
data were consistent with observations that the Del-p12 and DPY mutants
were defective in viral particle release and protein maturation and
that the defects in the Del-p12 mutant were more severe than those in
the DPY mutant. The fact that multiple virions in the DPY mutants could
bud out from the same location on the cell surface and remain connected
to form a "daisy chain" structure suggests that there may be some
preferred sites at the plasma membrane for virion budding.
Several of the insertion mutants were also analyzed by EM. The two
viable mutants (P2-PY and P6-PY) released virion particles indistinguishable from those of the wild type (Fig.
9A and B). Mutants P6-P12 and P6-MA
contained all three virus types seen with the DPY mutants, including
the immature viruses, chain structures, and very occasionally tube-like
structures (Fig. 9C and D). Therefore, these two mutants failed to
correct the virion release defects of the PPPY deletion mutant. All the
other mutants examined (PY-P12, PY-MA, P2-P12, and P2-MA) released
wild-type-like virions (data not shown). However, these mutants were
noninfectious, and no circular viral DNA could be detected in infected
NIH 3T3 cells (Fig. 5 and 6). Therefore, although the particles showed
normal morphology, these mutant viruses must be blocked during the
early events of the life cycle, suggesting that other Gag functions were disrupted by the insertions (Fig. 2 to 5).

View larger version (120K):
[in this window]
[in a new window]
|
FIG. 9.
EM images of virions released from 293T cells
transfected by the insertion mutants. (A) Mutant P2-PY. (B) Mutant
P6-PY. In these panels, black arrows point to mature virions and white
arrows point to immature virions (C) Mutant P6-P12. (D) Mutant P6-MA.
In these two panels, the chain structures are indicated by white arrows
and the tube structures are indicated by black arrows. Scale bars, 200 nm.
|
|
 |
DISCUSSION |
The results presented here show that the PPPY motif contained in
the M-MuLV p12 protein serves as an L-domain that is functionally interchangeable with the RSV and HIV-1 L-domains. The most compelling observation is that the insertion of the RSV p2b or HIV-1 p6 L-domain into the original location of the PPPY motif fully restored viral replication. Insertions of L-domains at several different locations of
Gag protein were able to fully or partially restore normal particle release.
L-domains were first identified during mutational analyses of the RSV
p2b protein (34). The crucial motif of the domain was
subsequently identified as a polyproline motif, PPPY, conserved in the
Gag precursors of many retroviruses (34). Mutation or deletion of this motif resulted in defects late in the course of virus
assembly and virion budding (34, 36-38). The L-domains of
the lentiviruses were distinctive: they are located in a small protein
(p6 for HIV-1 and p9 for EIAV) at the C terminus of Gag proteins and do
not contain a PPPY motif. Instead, the core sequence of these L-domains
consists of a PTAPP motif for HIV-1 and a YXXL motif for EIAV (19,
22). In spite of these different sequences, the L-domains of RSV,
HIV-1, and EIAV are functionally interchangeable for virus budding
(21, 22, 36). Data presented here demonstrate that the RSV
and HIV-1 L-domains can also restore viral assembly to an M-MuLV PPPY
mutant. Therefore, all these different retroviral L-domains may
function through a similar mechanism.
The position of insertion of the various L-domains had some effect on
the ability of the domain to rescue virion assembly. The RSV and M-MuLV
L-domains restored the assembly function more efficiently when inserted
in MA or p12 than when inserted in NC. In contrast, the HIV-1 p6
functioned better in NC than in MA or p12 (Fig. 2). These data suggest
that although the function of the L-domain is largely position
independent, the L-domain may function best when located near its
original, native location (relative to the N and C termini of the Gag protein).
Although previous reports have shown that swapping L-domains among
different retroviruses results in variant Gag proteins that are
competent for assembly, the infectivity of these chimeric viruses was
not determined (21, 22, 36). This report demonstrates that
the insertion of the RSV or HIV-1 L-domain at the location of the
original PPPY motif not only restored normal assembly to the M-MuLV
L-domain mutant but also generated a fully replication-competent virus.
The recovery of infectivity did not always require complete restoration
of efficient assembly; for example, the P6-PY mutant was infectious in
spite of modest defects in virion release and protein processing. Other
mutants, such as PY-P12, PY-MA, P2-P12, and P2-MA, showed efficient
budding and protein cleavage but were still noninfectious. One
explanation here could be that deletion of the PPPY motif in these
mutants disrupted the functions of p12 needed in an early phase of the
viral life cycle. Alternatively, insertions in MA or another position
of p12 might interfere with their functions during early events.
The mature wild-type M-MuLV virion assembles into a spherical particle
with an electron-dense core. Deletion of the L-domain in HIV-1 leads to
retention of immature virions on the cell surface, but no dramatic
changes in the overall morphology of the virion were observed
(13). In contrast, an M-MuLV mutant lacking the entire p12
directed the formation of elongated tubes or cylinders, which projected
perpendicularly outward from the plasma membrane, as the predominant
particle form. These cylindrical particles were reproducibly but less
frequently observed when only the PPPY motif was deleted. Presumably,
the proteins of the Gag precursor are somehow affected so that tubes
rather than spherical structures form. The virions are apparently
surrounded by membrane, since their buoyant density is at least grossly
similar to that of the wild type. Similar cylindrical particles were
previously observed when HIV-1 Gag deletion mutants (missing p6 and the
C-terminal half of NC) were overexpressed in insect cells
(17) and when certain M-PMV mutants with alterations in the
CA domain were expressed in mammalian cells (28). Other
viruses can also form rods under certain circumstances; influenza
viruses, for example, form rods in vivo, and the elongated forms are
thought to be harder for the host to remove from pulmonary airways than
are the spherical variants (9, 26, 27). It is unclear
whether the retroviral structures seen here reflect a similar capacity
for formation of filamentous virions under particular conditions.
Rod-like cylindrical structures have also been observed in assembly
studies in vitro using only the CA domain of HIV-1 (10, 15)
or the CA-NC fragment of RSV and HIV-1 Gag (6). More relevant to the present study is the observation that deletion of the
p10 domain in RSV, which is positionally analogous to p12 in M-MuLV,
resulted in the formation of cylindrical particles in vitro. From this
in vitro work with RSV, it was concluded that in addition to the M-,
I-, and L-domains, the p10 domain of RSV Gag acts as an S-domain
(shape-determining domain) (7). The results presented here
suggested that the p12 domain of M-MuLV is also a shape-determining
domain. It is not clear whether the shape-determining properties of p12
are inherent within Gag or whether an interaction with a cellular
factor is required. In vitro assembly studies using M-MuLV Gag proteins
are currently in progress to address this question.
The chain-structure particles assembled by the DPY mutant are even more
striking. These structures provide direct evidence that the PPPY motif
may function during the final stages of virion release. The presence of
the chains also suggests that the virions may bud out one after another
at the same site on the plasma membrane. It is possible that virions
may not assemble at random positions on the plasma membrane but that
some preferred exit points exist. Alternatively, budding of one virion
at a certain site of the plasma membrane could promote or "seed"
the formation of other virions at that same site. This process may be
coupled with recruitment of host cytoskeletal proteins to the site of
assembly. It would be interesting to determine whether reagents
affecting the cytoskeletal protein can affect these budding phenotypes.
Mutations in the PPPY motif partially block Gag protein cleavage and
completely block TM protein processing (38). These defects
could be corrected by insertions of the M-MuLV L-domain or by
insertions of other retroviral L-domains in different locations of the
Gag protein. As was true for viral assembly, inserting the L-domains
near their original locations resulted in better recovery of the
protein-processing function (Fig. 3 and 4). It is possible that the
viral protease activity or the accessibility of its substrate is
influenced by the L-domain. How the L-domain and the viral protease
work together is still unclear. Studies of protease-inactivated viruses
have revealed different results with different viruses. In HIV-1,
inactivation of the viral protease alleviated the requirement of p6 for
budding (19). In contrast, in both RSV and M-PMV, protease
inactivation did not alter the requirement of the late domains for
budding (34, 37). The L-domain may activate the protease or
may somehow allow the viral protease to recognize its substrates,
including the TM protein. It is also possible that host proteins may
interact with the L-domain and be involved in the activation of the
protease function.
Host proteins have long been suggested to participate in the L-domain
function, particularly since the PPPY motif can act as the binding site
for the WW motif, an important protein-protein interaction motif found
in many signal transduction and cytoskeletal proteins (29,
30; L. Garnier, J. W. Wills, M. F. Verderame, and
M. Sudol, Letter, Nature 381:744-745, 1996). One or more host proteins containing the WW motif may interact with the PPPY
motif of the retroviral L-domain and facilitate virion release. Further
studies are needed to identify which of the host proteins that bind to
the L-domain are important for its function. One puzzle is that there
is no primary sequence similarity among the HIV-1 p6, EIAV p9, and
M-MuLV L-domains (23). It is possible that three different
host proteins are used by these different viruses; alternatively, one
host protein may somehow bind all three motifs by using different contacts.
 |
ACKNOWLEDGMENTS |
We are grateful to Jason Gonsky for advice and for providing the
pNCSB plasmid, to Matthew Evans for preparing anti-p15E antiserum, and
to Andrew Yueh, Baojie Li, and Ari Fassati for helpful discussions. We
thank Theodora Hatziioannou, Nicole Bouvier, and Sharon Boast for
reading the early drafts. We also thank Kunio Nagashima for excellent
EM technical support.
This work was partially supported by Public Health Service grant CA
30488 from the National Cancer Institute. It was also partially
sponsored by the National Cancer Institute, Department of Health and
Human Services, under contract with ABL. S.P.G. is an Investigator
of the Howard Hughes Medical Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University College of Physicians and Surgeons, 701 W. 168th
St., New York, NY 10032. Phone: (212) 305-3794. Fax: (212) 305-8692. E-mail: goff{at}cuccfa.ccc.columbia.edu.
 |
REFERENCES |
| 1.
|
An, D. S.,
Y. Koyanagi,
J. Q. Zhao,
R. Akkina,
G. Bristol,
N. Yamamoto,
J. A. Zack, and I. S. Chen.
1997.
High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells.
J. Virol.
71:1397-1404[Abstract].
|
| 2.
|
Arcement, L.,
W. Karshin,
R. Naso,
G. Jamjoom, and R. Arlinghaus.
1976.
Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides.
Virology
69:763-774[CrossRef][Medline].
|
| 3.
|
Arcement, L. J.,
W. I. Karshin,
R. B. Naso, and R. B. Arlinghaus.
1977.
"Gag" polyprotein precursors of Rauscher murine leukemia virus.
Virology
81:284-297[CrossRef][Medline].
|
| 4.
|
Barnes, W. M.
1994.
PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates.
Proc. Natl. Acad. Sci. USA
91:2216-2220[Abstract/Free Full Text].
|
| 5.
|
Berthoux, L.,
C. Pechoux,
M. Ottmann,
G. Morel, and J. L. Darlix.
1997.
Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
J. Virol.
71:6973-6981[Abstract].
|
| 6.
|
Campbell, S., and V. M. Vogt.
1995.
Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
J. Virol.
69:6487-6497[Abstract].
|
| 7.
|
Campbell, S., and V. M. Vogt.
1997.
In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.
J. Virol.
71:4425-4435[Abstract].
|
| 8.
|
Colicelli, J., and S. P. Goff.
1988.
Sequence and spacing requirements of a retrovirus integration site.
J. Mol. Biol.
199:47-59[CrossRef][Medline].
|
| 9.
|
Cox, J. C.,
A. W. Hampson, and R. C. Hamilton.
1980.
An immunofluorescence study of influenza virus filament formation.
Arch. Virol.
63:275-284[CrossRef][Medline].
|
| 10.
|
Ehrlich, L. S.,
B. E. Agresta, and C. A. Carter.
1992.
Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro.
J. Virol.
66:4874-4883[Abstract/Free Full Text].
|
| 11.
|
Gao, G., and S. P. Goff.
1999.
Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection.
Mol. Biol. Cell
10:1705-1717[Abstract/Free Full Text].
|
| 12.
|
Gorelick, R. J.,
D. J. Chabot,
D. E. Ott,
T. D. Gagliardi,
A. Rein,
L. E. Henderson, and L. O. Arthur.
1996.
Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.
J. Virol.
70:2593-2597[Abstract].
|
| 13.
|
Gottlinger, H. G.,
T. Dorfman,
J. G. Sodroski, and W. A. Haseltine.
1991.
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
Proc. Natl. Acad. Sci. USA
88:3195-3199[Abstract/Free Full Text].
|
| 14.
|
Granowitz, C.,
R. D. Berkowitz, and S. P. Goff.
1996.
Mutations affecting the cytoplasmic domain of the Moloney murine leukemia virus envelope protein: rapid reversion during replication.
Virus Res.
41:25-42[CrossRef][Medline].
|
| 15.
|
Gross, I.,
H. Hohenberg, and H. G. Krausslich.
1997.
In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.
Eur. J. Biochem.
249:592-600[Medline].
|
| 16.
|
Hirt, B.
1967.
Selective extraction of polyoma DNA from infected mouse cell cultures.
J. Mol. Biol.
26:365-369[CrossRef][Medline].
|
| 17.
|
Hockley, D. J.,
M. V. Nermut,
C. Grief,
J. B. Jowett, and I. M. Jones.
1994.
Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1.
J. Gen. Virol.
75:2985-2997[Abstract/Free Full Text].
|
| 18.
|
Housset, V.,
H. De Rocquigny,
B. P. Roques, and J. L. Darlix.
1993.
Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity.
J. Virol.
67:2537-2545[Abstract/Free Full Text].
|
| 19.
|
Huang, M.,
J. M. Orenstein,
M. A. Martin, and E. O. Freed.
1995.
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
J. Virol.
69:6810-6818[Abstract].
|
| 20.
|
Leis, J.,
D. Baltimore,
J. M. Bishop,
J. Coffin,
E. Fleissner,
S. P. Goff,
S. Oroszlan,
H. Robinson,
A. M. Skalka,
H. M. Temin, and V. Vogt.
1988.
Standardized and simplified nomenclature for proteins common to all retroviruses.
J. Virol.
62:1808-1809[Abstract/Free Full Text].
|
| 21.
|
Parent, L. J.,
R. P. Bennett,
R. C. Craven,
T. D. Nelle,
N. K. Krishna,
J. B. Bowzard,
C. B. Wilson,
B. A. Puffer,
R. C. Montelaro, and J. W. Wills.
1995.
Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
J. Virol.
69:5455-5460[Abstract].
|
| 22.
|
Puffer, B. A.,
L. J. Parent,
J. W. Wills, and R. C. Montelaro.
1997.
Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.
J. Virol.
71:6541-6546[Abstract].
|
| 23.
|
Puffer, B. A.,
S. C. Watkins, and R. C. Montelaro.
1998.
Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly.
J. Virol.
72:10218-10221[Abstract/Free Full Text].
|
| 24.
|
Ragheb, J. A., and W. F. Anderson.
1994.
Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry.
J. Virol.
68:3207-3219[Abstract/Free Full Text].
|
| 25.
|
Rein, A.,
J. Mirro,
J. G. Haynes,
S. M. Ernst, and K. Nagashima.
1994.
Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
J. Virol.
68:1773-1781[Abstract/Free Full Text].
|
| 26.
|
Roberts, P. C., and R. W. Compans.
1998.
Host cell dependence of viral morphology.
Proc. Natl. Acad. Sci. USA
95:5746-5751[Abstract/Free Full Text].
|
| 27.
|
Roberts, P. C.,
R. A. Lamb, and R. W. Compans.
1998.
The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
Virology
240:127-137[CrossRef][Medline].
|
| 28.
|
Strambio-de-Castillia, C., and E. Hunter.
1992.
Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis.
J. Virol.
66:7021-7032[Abstract/Free Full Text].
|
| 29.
|
Sudol, M.
1996.
The WW module competes with the SH3 domain?
Trends Biochem. Sci.
21:161-163[CrossRef][Medline].
|
| 30.
|
Sudol, M.
1998.
From Src Homology domains to other signaling modules: proposal of the `protein recognition code'.
Oncogene
17:1469-1474[CrossRef][Medline].
|
| 31.
|
Swanstrom, R., and J. W. Wills.
1997.
Synthesis, assembly, and processing of viral proteins, p. 263-334.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 32.
|
Telesnitsky, A.,
S. Blain, and S. P. Goff.
1995.
Assays for retroviral reverse transcriptase.
Methods Enzymol.
262:347-362[Medline].
|
| 33.
|
Vogt, V. M.,
R. Eisenman, and H. Diggleman.
1975.
Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.
J. Mol. Biol.
96:471-493[CrossRef][Medline].
|
| 34.
|
Wills, J. W.,
C. E. Cameron,
C. B. Wilson,
Y. Xiang,
R. P. Bennett, and J. Leis.
1994.
An assembly domain of the Rous sarcoma virus Gag protein required late in budding.
J. Virol.
68:6605-6618[Abstract/Free Full Text].
|
| 35.
|
Wills, J. W., and R. C. Craven.
1991.
Form, function, and use of retroviral gag proteins.
AIDS
5:639-654[Medline].
|
| 36.
|
Xiang, Y.,
C. E. Cameron,
J. W. Wills, and J. Leis.
1996.
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain.
J. Virol.
70:5695-5700[Abstract/Free Full Text].
|
| 37.
|
Yasuda, J., and E. Hunter.
1998.
A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.
J. Virol.
72:4095-4103[Abstract/Free Full Text].
|
| 38.
|
Yuan, B.,
X. Li, and S. P. Goff.
1999.
Mutations altering the moloney murine leukemia virus p12 gag protein affect virion production and early events of the virus life cycle.
EMBO J.
18:4700-4710[CrossRef][Medline].
|
Journal of Virology, August 2000, p. 7250-7260, Vol. 74, No. 16
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Utley, T. J., Ducharme, N. A., Varthakavi, V., Shepherd, B. E., Santangelo, P. J., Lindquist, M. E., Goldenring, J. R., Crowe, J. E. Jr.
(2008). Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc. Natl. Acad. Sci. USA
105: 10209-10214
[Abstract]
[Full Text]
-
Ushijima, Y., Koshizuka, T., Goshima, F., Kimura, H., Nishiyama, Y.
(2008). Herpes Simplex Virus Type 2 UL56 Interacts with the Ubiquitin Ligase Nedd4 and Increases Its Ubiquitination. J. Virol.
82: 5220-5233
[Abstract]
[Full Text]
-
Popov, S., Popova, E., Inoue, M., Gottlinger, H. G.
(2008). Human Immunodeficiency Virus Type 1 Gag Engages the Bro1 Domain of ALIX/AIP1 through the Nucleocapsid. J. Virol.
82: 1389-1398
[Abstract]
[Full Text]
-
Gladnikoff, M., Rousso, I.
(2008). Directly Monitoring Individual Retrovirus Budding Events Using Atomic Force Microscopy. Biophys. J
94: 320-326
[Abstract]
[Full Text]
-
Zhadina, M., McClure, M. O., Johnson, M. C., Bieniasz, P. D.
(2007). Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc. Natl. Acad. Sci. USA
104: 20031-20036
[Abstract]
[Full Text]
-
Scheifele, L. Z., Kenney, S. P., Cairns, T. M., Craven, R. C., Parent, L. J.
(2007). Overlapping Roles of the Rous Sarcoma Virus Gag p10 Domain in Nuclear Export and Virion Core Morphology. J. Virol.
81: 10718-10728
[Abstract]
[Full Text]
-
Murphy, S. L., Gaulton, G. N.
(2007). TR1.3 Viral Pathogenesis and Syncytium Formation Are Linked to Env-Gag Cooperation. J. Virol.
81: 10777-10785
[Abstract]
[Full Text]
-
Watanabe, T., Sorensen, E. M., Naito, A., Schott, M., Kim, S., Ahlquist, P.
(2007). Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc. Natl. Acad. Sci. USA
104: 10205-10210
[Abstract]
[Full Text]
-
Low, A., Datta, S., Kuznetsov, Y., Jahid, S., Kothari, N., McPherson, A., Fan, H.
(2007). Mutation in the Glycosylated Gag Protein of Murine Leukemia Virus Results in Reduced In Vivo Infectivity and a Novel Defect in Viral Budding or Release. J. Virol.
81: 3685-3692
[Abstract]
[Full Text]
-
Bouamr, F., Houck-Loomis, B. R., De Los Santos, M., Casaday, R. J., Johnson, M. C., Goff, S. P.
(2007). The C-Terminal Portion of the Hrs Protein Interacts with Tsg101 and Interferes with Human Immunodeficiency Virus Type 1 Gag Particle Production. J. Virol.
81: 2909-2922
[Abstract]
[Full Text]
-
Irie, T., Shimazu, Y., Yoshida, T., Sakaguchi, T.
(2007). The YLDL Sequence within Sendai Virus M Protein Is Critical for Budding of Virus-Like Particles and Interacts with Alix/AIP1 Independently of C Protein. J. Virol.
81: 2263-2273
[Abstract]
[Full Text]
-
Agromayor, M., Martin-Serrano, J.
(2006). Interaction of AMSH with ESCRT-III and Deubiquitination of Endosomal Cargo. J. Biol. Chem.
281: 23083-23091
[Abstract]
[Full Text]
-
Auerbach, M. R., Brown, K. R., Kaplan, A., de Las Nueces, D., Singh, I. R.
(2006). A Small Loop in the Capsid Protein of Moloney Murine Leukemia Virus Controls Assembly of Spherical Cores. J. Virol.
80: 2884-2893
[Abstract]
[Full Text]
-
Hui, E. K.-W., Barman, S., Tang, D. H.-P., France, B., Nayak, D. P.
(2006). YRKL Sequence of Influenza Virus M1 Functions as the L Domain Motif and Interacts with VPS28 and Cdc42. J. Virol.
80: 2291-2308
[Abstract]
[Full Text]
-
Jin, S., Chen, C., Montelaro, R. C.
(2005). Equine Infectious Anemia Virus Gag p9 Function in Early Steps of Virus Infection and Provirus Production. J. Virol.
79: 8793-8801
[Abstract]
[Full Text]
-
Ott, D. E., Coren, L. V., Gagliardi, T. D., Nagashima, K.
(2005). Heterologous Late-Domain Sequences Have Various Abilities To Promote Budding of Human Immunodeficiency Virus Type 1. J. Virol.
79: 9038-9045
[Abstract]
[Full Text]
-
Stange, A., Mannigel, I., Peters, K., Heinkelein, M., Stanke, N., Cartellieri, M., Gottlinger, H., Rethwilm, A., Zentgraf, H., Lindemann, D.
(2005). Characterization of Prototype Foamy Virus Gag Late Assembly Domain Motifs and Their Role in Particle Egress and Infectivity. J. Virol.
79: 5466-5476
[Abstract]
[Full Text]
-
Lee, S.-K., Nagashima, K., Hu, W.-S.
(2005). Cooperative Effect of Gag Proteins p12 and Capsid during Early Events of Murine Leukemia Virus Replication. J. Virol.
79: 4159-4169
[Abstract]
[Full Text]
-
Johnson, M. C., Spidel, J. L., Ako-Adjei, D., Wills, J. W., Vogt, V. M.
(2005). The C-Terminal Half of TSG101 Blocks Rous Sarcoma Virus Budding and Sequesters Gag into Unique Nonendosomal Structures. J. Virol.
79: 3775-3786
[Abstract]
[Full Text]
-
Schmitt, A. P., Leser, G. P., Morita, E., Sundquist, W. I., Lamb, R. A.
(2005). Evidence for a New Viral Late-Domain Core Sequence, FPIV, Necessary for Budding of a Paramyxovirus. J. Virol.
79: 2988-2997
[Abstract]
[Full Text]
-
Gurer, C., Berthoux, L., Luban, J.
(2005). Covalent Modification of Human Immunodeficiency Virus Type 1 p6 by SUMO-1. J. Virol.
79: 910-917
[Abstract]
[Full Text]
-
Eastman, S. W., Martin-Serrano, J., Chung, W., Zang, T., Bieniasz, P. D.
(2005). Identification of Human VPS37C, a Component of Endosomal Sorting Complex Required for Transport-I Important for Viral Budding. J. Biol. Chem.
280: 628-636
[Abstract]
[Full Text]
-
Martin-Serrano, J., Eastman, S. W., Chung, W., Bieniasz, P. D.
(2005). HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J. Cell Biol.
168: 89-101
[Abstract]
[Full Text]
-
Muriaux, D., Costes, S., Nagashima, K., Mirro, J., Cho, E., Lockett, S., Rein, A.
(2004). Role of Murine Leukemia Virus Nucleocapsid Protein in Virus Assembly. J. Virol.
78: 12378-12385
[Abstract]
[Full Text]
-
Melamed, D., Mark-Danieli, M., Kenan-Eichler, M., Kraus, O., Castiel, A., Laham, N., Pupko, T., Glaser, F., Ben-Tal, N., Bacharach, E.
(2004). The Conserved Carboxy Terminus of the Capsid Domain of Human Immunodeficiency Virus Type 1 Gag Protein Is Important for Virion Assembly and Release. J. Virol.
78: 9675-9688
[Abstract]
[Full Text]
-
Heidecker, G., Lloyd, P. A., Fox, K., Nagashima, K., Derse, D.
(2004). Late Assembly Motifs of Human T-Cell Leukemia Virus Type 1 and Their Relative Roles in Particle Release. J. Virol.
78: 6636-6648
[Abstract]
[Full Text]
-
Martin-Serrano, J., Perez-Caballero, D., Bieniasz, P. D.
(2004). Context-Dependent Effects of L Domains and Ubiquitination on Viral Budding. J. Virol.
78: 5554-5563
[Abstract]
[Full Text]
-
Blot, V., Perugi, F., Gay, B., Prevost, M.-C., Briant, L., Tangy, F., Abriel, H., Staub, O., Dokhelar, M.-C., Pique, C.
(2004). Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. J. Cell Sci.
117: 2357-2367
[Abstract]
[Full Text]
-
Irie, T., Licata, J. M., McGettigan, J. P., Schnell, M. J., Harty, R. N.
(2004). Budding of PPxY-Containing Rhabdoviruses Is Not Dependent on Host Proteins TGS101 and VPS4A. J. Virol.
78: 2657-2665
[Abstract]
[Full Text]
-
Wang, H., Machesky, N. J., Mansky, L. M.
(2004). Both the PPPY and PTAP Motifs Are Involved in Human T-Cell Leukemia Virus Type 1 Particle Release. J. Virol.
78: 1503-1512
[Abstract]
[Full Text]
-
Guo, X., Hu, J., Whitney, J. B., Russell, R. S., Liang, C.
(2004). Important Role for the CA-NC Spacer Region in the Assembly of Bovine Immunodeficiency Virus Gag Protein. J. Virol.
78: 551-560
[Abstract]
[Full Text]
-
Shehu-Xhilaga, M., Ablan, S., Demirov, D. G., Chen, C., Montelaro, R. C., Freed, E. O.
(2004). Late Domain-Dependent Inhibition of Equine Infectious Anemia Virus Budding. J. Virol.
78: 724-732
[Abstract]
[Full Text]
-
Bouamr, F., Melillo, J. A., Wang, M. Q., Nagashima, K., de Los Santos, M., Rein, A., Goff, S. P.
(2003). PPPYEPTAP Motif Is the Late Domain of Human T-Cell Leukemia Virus Type 1 Gag and Mediates Its Functional Interaction with Cellular Proteins Nedd4 and Tsg101. J. Virol.
77: 11882-11895
[Abstract]
[Full Text]
-
Martin-Serrano, J., Bieniasz, P. D.
(2003). A Bipartite Late-Budding Domain in Human Immunodeficiency Virus Type 1. J. Virol.
77: 12373-12377
[Abstract]
[Full Text]
-
Rein, A.
(2003). Genetic footprinting of a retroviral Gag gene suggests an important role in virus replication. Proc. Natl. Acad. Sci. USA
100: 11929-11930
[Full Text]
-
Martin-Serrano, J., Yarovoy, A., Perez-Caballero, D., Bieniasz, P. D.
(2003). Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. USA
100: 12414-12419
[Abstract]
[Full Text]
-
Auerbach, M. R., Shu, C., Kaplan, A., Singh, I. R.
(2003). Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting. Proc. Natl. Acad. Sci. USA
100: 11678-11683
[Abstract]
[Full Text]
-
Goff, A., Ehrlich, L. S., Cohen, S. N., Carter, C. A.
(2003). Tsg101 Control of Human Immunodeficiency Virus Type 1 Gag Trafficking and Release. J. Virol.
77: 9173-9182
[Abstract]
[Full Text]
-
Gottwein, E., Bodem, J., Muller, B., Schmechel, A., Zentgraf, H., Krausslich, H.-G.
(2003). The Mason-Pfizer Monkey Virus PPPY and PSAP Motifs Both Contribute to Virus Release. J. Virol.
77: 9474-9485
[Abstract]